Acute promyelocytic leukemia. M.D. Anderson hospital experience

The American Journal of Medicine

Volumn 80, Issue 5, 1986, Pages 789-797

  Kantarjian, Hagop M ^a   Keating, Michael J ^a   Walters, Ronald S ^a   Estey, Elihu H ^a   McCredie, Kenneth B ^a   Smith, Terry L ^a   Dalton Jr , Willard T ^a   Cork, Ann ^a   Trujillo, Jose M ^a   Freireich, Emil J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; BCG VACCINE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; HEPARIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; BLEEDING; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG COMPARISON; DRUG EFFICACY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTE; THERAPY;

6-MERCAPTOPURINE; AMINOACRIDINES; AMSACRINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; CYTARABINE; DAUNORUBICIN; DISSEMINATED INTRAVASCULAR COAGULATION; DOXORUBICIN; FEMALE; HEMORRHAGE; HOSPITALS, TEACHING; HOSPITALS, UNIVERSITY; HUMANS; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RISK; TEXAS; TIME FACTORS; VINCRISTINE;

EID: 0022522965     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(86)90617-0     Document Type: Article

References (38)

1. A four-year experience with anthracycline, cytosine arabinoside, vincristine, and prednisone combination in 325 adults with acute leukemia
2. Treatment of acute leukemia in adults
3. Acute promyelocytic leukemia: results of treatment by daunorubicin
4. Acute promyelocytic leukaemia
5. Acute promyelocytic leukemia
6. Clinical and morphologic correlations in acute promyelocytic leukemia
7. Partial deletion of long arm of chromosome 17
8. Chromosome abnormalities in acute promyelocytic leukemia (APL)
9. Fourth International Workshop on Chromosomes in Leukemia
10. Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia
11. Acute promyelocytic leukaemia: haemorrhagic manifestation and morphologic criteria
12. Prophylactic heparin therapy in acute promyelocytic leukemia
13. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia
14. Prognostic factors in acute promyelocytic leukemia (APL): a retrospective study of 101 patients treated by DNR containing remission induction regimen (abstr 590)
15. Acute promyelocytic leukemia (APL): ten year's experience (abstr C-790)
16. Acute promyelocytic leukemia: management of the coagulopathy during daunorubicin-prednisone remission induction
17. Proposals for the classification of the acute leukemias
18. Chromosomes in leukemia and lymphoma with special emphasis on methodology
19. Hematologic and cytologic characterization of 8; 21 translocation acute granulocytic leukemia
20. ISCN (1981) an international system for human cytogenetic nomenclature-high resolution banding
21. Nonparametric estimation from incomplete observations
22. Prognostic factors in acute leukemia
23. A variant form of hypergranular promyelocytic leukemia (M3)
24. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture
25. Acute promyelocytic leukemia: results of therapy and analysis of 13 cases
26. Acute promyelocytic leukemia: clinical management of 15 patients
27. Acute promyelocytic leukaemia: a study of 39 cases with identification of a hyperbasophilic macrogranular variant
28. A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia
29. Marrow transplant for acute nonlymphoblastic leukemia in first remission: a follow-up
30. Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy
31. Acute promyelocytic leukemia
32. Therapy and survival in adult acute promyelocytic leukemia (abstr)
33. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds
34. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester
35. The differentiation of myeloid leukemia cells: new possibilities for therapy
36. Low dose arabinosylcytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia
37. Does treatment with ara-C in low dosage cause differentiation of leukemic cells?